SIRPA and neoplasm: On the other hand, high-affinity SIRPα monomers (~14 kDa) are not sufficient to induce macrophage phagocytosis, instead, act as an adjuvant to lower the threshold for phagocytosis in the presence of a separate, tumor-binding antibody.